- Connecticut Innovations announces $9.4 million in investments in early-stage Connecticut companies for the third quarter of its fiscal year
- Investments are concentrated in bioscience, health care information technology, and IT companies
- Funding helps leverage $124 million in outside capital
Summary by Dirk Langeveld
Connecticut Innovations announced that it invested $9.4 million in early-stage companies in Connecticut in the third quarter of its fiscal year, which ended March 31. The investment marks an increase from the second quarter, which saw $7.2 million in investments.
Connecticut Innovations said the investments:
- Involved 36 transactions
- Allocated $4.3 million to bioscience and health care information technology companies, as well as $1.8 million to IT companies
- Leveraged $124 million in outside capital
- Provided the largest sums to the Mystic-based agricultural science company Enko Chem, the New Haven-based health software company Inbox Health, the lung cancer treatment company Lumeda of Rocky Hill, and the autonomous maritime surveillance company ThayerMahan of Groton
